Результати пошуку - B Charpentier

  • Показ 1 - 11 результатів із 11
Уточнити результати
  1. 1
    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study

    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study за авторством Nassim Kamar, Valérie Garrigue, A. Karras, G. Mourad, N Lefrançois, B Charpentier, Christophe Legendre, Lionel Rostaing

    Опубліковано 2006
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS

    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS за авторством F. Vincenti, J. Grinyó, Christian P. Larsen, José Osmar Medina Pestana, Yves Vanrenterghem, Tao Duan, Mamta Agarwal, B Charpentier

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT)

    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT) за авторством F. Vincenti, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Lionel Rostaing, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Christian P. Larsen

    Опубліковано 2010
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY

    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY за авторством Christian P. Larsen, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Nassim Kamar, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Pushkal Garg, F. Vincenti

    Опубліковано 2010
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia за авторством Maurizio Salvadori, Klemens Budde, B Charpentier, Jürgen Klempnauer, Björn Nashan, Luis Pallardó, Josette Eris, Francesco Paolo Schena, Ute Eisenberger, Lionel Rostaing, Abdel Hmissi, Shreeram Aradhye

    Опубліковано 2006
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers

    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents a... за авторством A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein

    Опубліковано 1993
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials

    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials за авторством Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, G. Mondragon-Ramirez, Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, S Schleibner, Nassim Kamar

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study за авторством Rachel Hellemans, Marc Hazzan, D. Durand, G. Mourad, P Lang, Martin Kessler, B Charpentier, Guy Touchard, F. Berthoux, Pierre Merville, Nacéra Ouali, J.P. Squifflet, François Bayle, Karl Martin Wissing, C. Noël, Daniel Abramowicz

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients за авторством Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcı́a, J. Kothari, Philippe Lang, Eduardo Mancilla Urrea, P. Massari, G. Mondragon-Ramirez, Rafael Reyes‐Acevedo, Kim Rice, Lionel Rostaing, S. Steinberg, J. Xing, Mamta Agarwal, M. Harler, B Charpentier

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Rand... за авторством Philippe Gatault, Nassim Kamar, M. Büchler, Claudio Colosio, Dominique Bertrand, Antoine Dürrbach, Laetitia Albano, J Rivalan, Yannick Le Meur, Marie Essig, Nicolas Bouvier, Christophe Legendre, Bruno Moulin, A.E. Heng, P.-F. Weestel, Johnny Sayegh, B Charpentier, Lionel Rostaing, Éric Thervet, Yvon Lebranchu

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice за авторством Paula M. Chilton, Smita Ghare, B Charpentier, S Myers, Aakarsha V. Rao, Joseph F. Petrosino, Kristi L. Hoffman, John C. Greenwell, Neetu Tyagi, Jyotirmaya Behera, Yali Wang, Lucy Sloan, JingWen Zhang, Christopher Shields, Gregory E. Cooper, Leila Gobejishvili, Scott R. Whittemore, Craig J. McClain, Shirish Barve

    Опубліковано 2024
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: